Article info

Download PDFPDF
Non-fusion mutations in endometrial stromal sarcomas: what is the potential impact on tumourigenesis through cell cycle dysregulation?

Authors

  • Snehal B Patel Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA Molecular Diagnostics Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Strata Oncology, Ann Arbor, MI, United States PubMed articlesGoogle scholar articles
  • Colin McCormack Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA Baylor Scott & White Medical Center-Temple, Temple, TX, United States PubMed articlesGoogle scholar articles
  • Jennelle C Hodge Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA Department of Medical and Molecular Genetics, Indiana University, Indianapolis, IN, USA Department of Pediatrics, University of California Los Angeles, Los Angeles, CA, United States PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jennelle C Hodge, Department of Medical and Molecular Genetics, Indiana University, Indianapolis, IN 46202, USA; jhodge1{at}iu.edu
View Full Text

Citation

Patel SB, McCormack C, Hodge JC
Non-fusion mutations in endometrial stromal sarcomas: what is the potential impact on tumourigenesis through cell cycle dysregulation?

Publication history

  • Received February 4, 2020
  • Revised March 30, 2020
  • Accepted April 23, 2020
  • First published May 8, 2020.
Online issue publication 
November 19, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.